Health ❯ Healthcare

Conditions

Neurological Disorders Hypertension Musculoskeletal Disorders Cardiovascular Diseases Arthritis Gastrointestinal Disorders Diabetes Skin Conditions Pancreatitis Chronic Conditions Osteoarthritis Cardiovascular Health Obesity Respiratory Conditions Allergies Common Ailments Headaches Dementia Sepsis Anemia Hair Loss Alopecia Hypothyroidism Dermatology Migraine Heart Disease Spinal Conditions Pericarditis Kidney Disease Endometriosis Autoimmune Diseases Bone Health Long COVID Normal Pressure Hydrocephalus Urinary Tract Infections Pulmonary Conditions Genetic Disorders Maternal Health Epilepsy Women's Health Hidrocefalia Paralysis Sinusitis Skin Disorders Cancer Hair Disorders Myocarditis Weight Loss Temporary Hair Loss Vitamin Deficiency Hearing Impairment Gynecological Conditions Liver Conditions Cystitis Sarcopenia Anaemia Seizures Pulmonary Hypertension Liver Disease Thyroid Disorders Hyperhidrosis Hypoglycemia Hypertriglyceridemia Chronic Pain Kidney Stones Obstructive Sleep Apnea Hair Loss Myths Eye Health Types of Hair Loss Vision Loss Men's Health Ear Disorders Angina Nutritional Deficiencies Common Health Issues Respiratory Issues Respiratory Infections Neurofibromatosis Nerve Pain Mouth Ulcers Brain Tumors Gastroesophageal Reflux Disease Hemophilia Eye Conditions Strokes Inflammatory Bowel Disease Heart disease Bone Disorders Cardiovascular Conditions Acid Reflux Vision Disorders Stomach Issues Respiratory Disorders Gallstones Age-related Risks Pregnancy Psoriasis Back Pain Postpartum Conditions Asthma

Major Rugby Recalls 12 Batches of Levothyroxine Nationwide

FDA testing found the tablets are subpotent, prompting instructions to verify lot numbers with pharmacies before altering treatment.

Resorbable‑Microsphere Embolization Cuts Knee Osteoarthritis Pain for a Year

BMJ Review: Aerobic Exercise Works Best for Knee Osteoarthritis

Vanessa Hudgens Shares Postpartum Hair Loss in Candid Instagram Update

FDA Clears Teva’s Ponlimsi, a Prolia Biosimilar, for All Indications

CHAMPION-AF: Watchman FLX Matches NOACs on Ischemic Events and Cuts Bleeding Over 3 Years

FDA Clears J&J’s Icotyde, First Oral IL-23 Psoriasis Therapy for Ages 12 and Up

Lilly Combo of Zepbound and Taltz Tops Taltz Alone in Late-Stage Psoriasis Trials

Sanofi Pushes Amlitelimab Toward 2026 Filings After Mixed Phase 3 Readouts

Boston Scientific to Acquire Penumbra for $14.5 Billion

FDA Adds Brain Tumor Warning to Two Depo‑Provera Injections

FDA Approves Koselugo for Adults With NF1-Related Plexiform Neurofibromas

Largest Post-COVID Smell Study Finds Lasting Loss, Often Without Symptoms

Apple Watch Hypertension Alerts Go Live With FDA Clearance

Ionis’ Olezarsen Slashes Triglycerides, Cuts Pancreatitis in Phase 3 Trials

GLP-1 Agonists Cut Dementia and Mortality Risk Versus Metformin in Type 2 Diabetes

One-Minute Doppler Ultrasound Validated as Cuff-Free Peripheral Artery Disease Test

AAV-OTOF Gene Therapy Restores Hearing in Teens and Adults

FDA Expands Myocarditis and Pericarditis Warnings on mRNA COVID-19 Vaccines

Early Dog Exposure Lowers Eczema Risk in Genetically Susceptible Children